Delia Dima

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 347 citations

Pharmacy, Hematology, Pharmacotherapy +5

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA<i>CCAT2</i>induce myeloid malignancies via unique SNP-specific RNA mutations

Maitri Shah, Manuela Ferracin, Valentina Pileczki et al. · Genome Research · 2018 · 65 citations · Full text

Medicine, Genetics, Oncology +17

<i>CAT, GPX1, MnSOD, GSTM1, GSTT1</i>, and<i>GSTP1</i>Genetic Polymorphisms in Chronic Myeloid Leukemia: A Case-Control Study

Claudia Bănescu, Adrian P. Trifa, Septimiu Voidăzan et al. · Oxidative Medicine and Cellular Longevity · 2014 · 46 citations · Full text

Life Sciences, Genetics, Oncology +17

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy

Ciprian Tomuleasa, Bobe Petrushev, Sanda Boca et al. · International Journal of Nanomedicine · 2016 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

SERS assessment of the cancer-specific methylation pattern of genomic DNA: towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell transplantation

Vlad Moisoiu, Andrei Ştefancu, Ștefania D. Iancu et al. · Analytical and Bioanalytical Chemistry · 2019 · 41 citations

Medicine, Hematology, Oncology +17